Table 4 Association between baseline characteristics and being overweight or obese in the Temprano trial, Abidjan, March 2008–December 2012 (N = 755)

Sex

Women/men

1.74

1.13–2.68

0.01

2.33

1.46–3.72

0.0004

Age

/5 years

1.10

1.05–1.15

0.03

1.14

1.08–1.20

0.006

Employed

Yes/no

1.35

0.94–1.93

0.09

–

–

–

Nationality

Ivoirian/non-ivoirian

1.45

0.87–2.42

0.15

–

–

–

Marital status

Married/single

1.68

1.18–2.39

0.007

–

–

–

Divorced/single

1.75

1.07–2.87

–

–

Living conditions

Moderate vs bad

1.56

0.93–2.61

0.001

1.76

1.03–3.01

0.001

Best vs bad

2.37

1.42–3.95

2.61

1.53–4.45

Smoker

Yes/no

0.49

0.24–0.98

0.03

–

–

–

Alcohol use

Yes/no

0.98

0.70–1.36

0.92

–

–

–

WHO stage

2 vs 1

0.67

0.45-0.99

0.0007

0.71

0.47–1.07

0.006

3 vs 1

0.27

0.13–0.56

0.32

0.15–0.68

HBP (≥140/90 mmHg)

Yes/no

4.38

2.22–8.63

0.0001

4.36

2.06–9.20

0.0001

CD4 count

350–500 vs ≤350

1.19

0.79–1.81

0.54

–

–

–

>500 vs ≤350/mm³

1.26

0.82-1.92

–

–

–

Viral load

/1 log

0.90

0.79–1.04

0.16

–

–

–

Hemoglobin ≥95 g/dL

Yes/no

2.75

1.50–5.05

0.001

3.09

1.63–5.86

0.0005

HyperTG

Yes/no

1.72

0.55–5.34

0.34

LDL >4.13 mmol/L

Yes/no

1.51

0.95–2.41

0.07

–

–

–

Hyperglycemia

Yes/no

0.91

0.09–8.82

0.93

–

–

–